TABLE 1

Comparison of commonly used LARCs, all with > 99% efficacya

BrandLARC typeProgestogen, doseSize, mmFDA-approved duration of useData-supported duration of useBleeding patternsAmenorrhea according to package insertOther clinical pearls
MirenaLevonorgestrel-IUD52 mg32 x 328 years8 yearsMore likely to have significantly decreased menstrual bleeding and pain, especially after 1 year of use
Progestin-only methods may be associated with irregular bleeding and
1 year: 20%
5 years: 40%
Approved for treatment of heavy menstrual bleeding
Can be used as emergency contraception56
LilettaLevonorgestrel-IUD52 mg32 x 328 years8 yearsspotting1 year: 19%
5 years: 40%
More affordable for patients with limited insurance coverage
KyleenaLevonorgestrel-IUD19.5 mg28 x 305 years5 years1 year: 12%
5 years: 23%
Smaller size may be more suitable to nulliparous patients or those with anatomically smaller uterus
SkylaLevonorgestrel-IUD13.5 mg28 x 303 years3 years1 year: 6%
3 years: 12%
ParagardCopper IUDHormone-free32 x 3610 years12 yearsPossible increased amount and duration of menstrual bleedingNo causal relationship establishedCan be used as emergency contraception
Best for highly effective contraception that is hormone free (ie, after breast cancer)
When used during age of mid-late 30s, can provide contraception into menopause transition
NexplanonSubdermal etonogestrel implant68 mg2 x 403 years5 yearsUnpredictable bleeding pattern, though lightens over time for most2 years: 20%Does not require a pelvic examination
Easy to learn procedure, training via drug company as opposed to clinician
  • a All the contraceptives are the most-effective contraceptive methods; safe in breastfeeding; no long-term effects on fertility, fertility is immediate following discontinuation; safe for women who cannot or prefer not to take estrogen.

  • FDA = US Food and Drug Administration; IUD = intrauterine device; LARC = long-acting reversible contraceptives

  • Based on data from references 5, 6, 53, and 56.